Trials / Completed
CompletedNCT04861688
NeuroAiD II™ (MLC901) in Mild Traumatic Brain Injury
A Randomized Double-blind, Placebo-controlled, Multi-center Trial to Investigate the Efficacy and Safety of NeuroAiD II™ (MLC901) to Improve Cognitive Functioning in Non-surgical Mild Traumatic Brain Injury Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 182 (actual)
- Sponsor
- Moleac Pte Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
A Randomized Double-blind, Placebo-controlled, Multi-center Trial to determine the efficacy of NeuroAiD II™ (MLC901) in improvement of cognitive functioning of adult patients with long-term cognitive impairment following mild traumatic brain injury (mTBI) and to assess safety of NeuroAiD™ (MLC901) in these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Traditional Chinese Medicine (NeuroAiD II™ (MLC901) | NeuroAiD II™ (MLC901) contains the extracts of 9 botanical active ingredients blended with commonly used excipients. The 9 botanical active ingredients are traditional herbs well documented in the Pharmacopoeia of the People's Republic of China. |
| OTHER | Placebo | Placebo with same appearance as active intervention |
Timeline
- Start date
- 2021-08-23
- Primary completion
- 2023-02-14
- Completion
- 2023-02-14
- First posted
- 2021-04-27
- Last updated
- 2023-03-15
Locations
4 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT04861688. Inclusion in this directory is not an endorsement.